Efficacy and safety of direct oral anticoagulants versus warfarin in obese patients: a systematic review and meta-analysis of 31 studies
P Karakasis, N Ktenopoulos… - European Journal of …, 2024 - academic.oup.com
Background Based on current guidelines and consensus documents, the use of direct oral
anticoagulants (DOACs) in obese patients (body mass index [BMI]> 30 kg/m2) is not …
anticoagulants (DOACs) in obese patients (body mass index [BMI]> 30 kg/m2) is not …
Efficacy and safety of direct oral anticoagulants versus warfarin in obese patients: a systematic review and meta-analysis of 31 studies
P Karakasis, N Ktenopoulos… - European Journal of …, 2024 - academic.oup.com
Background Based on current guidelines and consensus documents, the use of direct oral
anticoagulants (DOACs) in obese patients (body mass index [BMI]> 30 kg/m2) is not …
anticoagulants (DOACs) in obese patients (body mass index [BMI]> 30 kg/m2) is not …